BASTYR UNIVERSITY RESEARCH INSTITUTE AWARDED $4.52 MILLION GRANT

2010 | October, Naturopathic News

BASTYR UNIVERSITY RESEARCH INSTITUTE AWARDED $4.52 MILLION GRANT

Award is in collaboration with the University of Washington, Fred Hutchinson Cancer Research Center and University of Minnesota

Kenmore, Wash. (Sept. 24, 2010) — Bastyr University’s cancer research studies will advance well into the middle of the decade, thanks to a new grant the University received in partnership with the University of Washington. Bastyr was awarded $4.52 million over the next four years for the Bastyr/UW Oncomycology Translational Research Center, which will study the healing power of Asian medicinal mushrooms on breast and prostate cancer.

“As the leading higher education institution in natural health arts and sciences, Bastyr University is at the forefront of cutting edge wellness research and global collaborations,” University President Daniel K. Church, PhD, said. “This grant will fund rigorous studies relating to natural treatment of prostate and breast cancer.”

The funding comes from the National Institutes of Health’s (NIH) National Center for Complementary and Alternative Medicine (NCCAM) and bolsters Bastyr’s already strong Research Institute, which has conducted more than 100 basic and clinical research studies in integrative, complementary and alternative medicine through the years.

Co-principal investigators on the grant are Leanna J. Standish, ND, PhD, LAc, FABNO, from Bastyr and Mary L. (Nora) Disis, MD, of the Translational Medicine and Women’s Health and Tumor Vaccine Group at the University of Washington. Other collaborators include Celestia Higano, MD, FACP, who directs the UW Prostate Cancer Clinical Research Group, and researchers with both the Fred Hutchinson Cancer Research Center and the Developmental Center for Research in Complementary Alternative Medicine (DCRC) at the University of Minnesota.

The announcement of this latest award follows a $3.1 million grant Bastyr received jointly with Seattle’s Fred Hutchinson Cancer Research Center in July 2010. That grant was awarded by the NIH and focuses on the study of complementary and integrative care for breast cancer.

“The public’s increased interest in natural health care has created a growing need for basic and clinical research in natural health practices,” Dr. Church said. “To help meet that need, Bastyr University has steadily expanded its research efforts for more than a quarter century. This research is a fundamental part of our mission, and we are proud to be one of the international leaders in this field.”

Advertisement

Current Issue

Table of Contents

Advertisement

Trending Articles

Metagenics Names Patrick Sly as CEO to Lead Next Chapter of Growth

Metagenics Names Patrick Sly as CEO to Lead Next Chapter of Growth

Aliso Viejo, CA – December 1, 2025 Metagenics, a leading  doctor-recommended professional supplement announced it has named Patrick Sly as CEO, effective immediately. A highly regarded executive in the health and wellness industry, Mr. Sly brings a wealth of...

FDA Removes Black Box Warnings from Hormone Replacement Therapy

FDA Removes Black Box Warnings from Hormone Replacement Therapy

New review of research shows benefits outweigh risks for women who start treatment within 10 years of menopause onset After more than two decades, the FDA is finally removing the black box warnings that have kept millions of women from accessing hormone replacement...

Naturopathic Doctor Continues Walk Across USA for Health Equity

Naturopathic Doctor Continues Walk Across USA for Health Equity

Fargo, ND - Dennis Godby, 69, ND, MA, a Sacramento, CA-Licensed Naturopathic Doctor (ND), to raise awareness across the USA of significant health disparities, and support the “Health Equity,” movement, will continue his inspiring 756 mile walking trek across America...

Custom Publishing

IS TYLENOL SAFE DURING PREGNANCY?

IS TYLENOL SAFE DURING PREGNANCY?

Understanding Risk Factors, Not Causation Learn how much Tylenol pregnant women can safely take, what risk factors matter, and why glutathione status—not acetaminophen itself—determines safety during pregnancy.   IN THIS ARTICLE • Key Takeaways: Tylenol Safety...

Featured News